MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

STN-DBS Targeting SNr Modulates Sleep in Parkinson’s Disease: A Proof-of-Concept Study

HL. Yu, LX. Guan, YN. Sui, F. Ba, LM. Li (Beijing, China)

Meeting: 2022 International Congress

Abstract Number: 346

Keywords: Deep brain stimulation (DBS), Sleep disorders. See also Restless legs syndrome: Treatment, Substantia nigra

Category: Surgical Therapy: Parkinson's Disease

Objective: To explore how subthalamic deep brain stimulation (STN-DBS) targeting substantia nigra pars reticulata (SNr) can modulate sleep in Parkinson’s disease (PD) patients with electrophysiologic measures.

Background: STN-DBS has been shown to improve sleep in PD. However, the pattern of sleep modulation is unclear. Previous in vivo studies have found that SNr has a critical role in sleep modulation through basal ganglia-brainstem circuitry, but objective measures jn PD sleep patterns are are lacking.

Method: In this proof-of-concept study, we studied the sleep pattern in two PD patients more than one year after STN-DBS surgery whose motor control was optimized [Patient 1 (P1), Patient 2 (P2)]. Three discontinuous nocturnal sleeps monitoring with polysomnography were performed. Electrode location of STN-DBS and the location of SNr were verified and volume of tissue activation was calculated. The most ventral contact was used as SNr target. The DBS programming was set at baseline, or high frequency SNr stimulation (130Hz, 60us, HFS-V) or low frequency SNr stimulation (80Hz or 60Hz, 60us, LFS-V), respectively. In Patient 1(P1), DBS was switched to HFS-V or LFS-V in N2 stage and back to baseline in N1, N3 and REM stage during nocturnal sleep. In P2, interleaving mode was used so as to add ventral stimulation while retaining the original stimulus parameters during whole sleep.

Results: Demographic characters and DBS parameters were shown in Table 1. Although stimulation of SNr alone showed motor deterioration in P1 during parameter testing, there was no compromise with motor control upon switching back to the baseline parameters from the two new settings upon waking up (Figure 1 C). Sleep efficiency and arousal index were improved in HFS-V and LFS-V (Figure 1D, E). REM sleep latency was decreased with SNr stimulation (Figure 1 F). Analysis of power spectrum density (PSD) before and after SNr stimulation in N2 stage in P1 (Pseudo-stimulus sites were similarly selected in baseline N2 stage) showed increased δ band PSD with SNr stimulation, especially with LFS-V (Figure 2).

Conclusion: In this proof-of-concept study, we showed that STN-DBS targeting SNr during sleep has influenced sleep architecture and improve sleep quality in PD without impacting daytime motor function, shedding some light on the sleep modulation effect of SNr stimulation.

Figure 1

Table 1

Figure 2

To cite this abstract in AMA style:

HL. Yu, LX. Guan, YN. Sui, F. Ba, LM. Li. STN-DBS Targeting SNr Modulates Sleep in Parkinson’s Disease: A Proof-of-Concept Study [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/stn-dbs-targeting-snr-modulates-sleep-in-parkinsons-disease-a-proof-of-concept-study/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/stn-dbs-targeting-snr-modulates-sleep-in-parkinsons-disease-a-proof-of-concept-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley